SCHEMBL30784255

SCHEMBL30784255

Cc1cc([C@@H](C)N)c2nc(N3CCOCC3)n(C3CC3)c(=O)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ AKT1 P31749 1/20 0.39
▸ AKT2 P31751 1/20 0.39
▸ AKT3 Q9Y243 1/20 0.39
▸ CCNC P24863 5/20 0.38
▸ CDK8 P49336 5/20 0.38
▸ PIK3CB P42338 13/20 0.38
▸ CSNK2A2 P19784 1/20 0.36
▸ CCNA2 P20248 1/20 0.36
▸ CCNE1 P24864 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ CSNK1A1 P48729 1/20 0.36
▸ CLK1 P49759 1/20 0.36
▸ CLK2 P49760 1/20 0.36
▸ CDK7 P50613 1/20 0.36
▸ CCNH P51946 1/20 0.36
▸ MNAT1 P51948 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30784266 0.96 PIK3CB (0.38) ALDH1A1AKT1AKT2AKT3CCNC
SCHEMBL30784348 0.87 AKT1 (0.47) AKT1AKT2AKT3PIK3CB
SCHEMBL30783583 0.87 AKT1 (0.47) AKT1AKT2AKT3PIK3CB
SCHEMBL30784529 0.84 AKT1 (0.41) AKT1AKT2AKT3PIK3CB
SCHEMBL30783689 0.84 PIK3CB (0.39) AKT1AKT2AKT3PIK3CB
SCHEMBL30784478 0.83 AKT1 (0.44) AKT1AKT2AKT3PIK3CB
SCHEMBL30784377 0.83 CCNC (0.45) CYP1A2ALDH1A1CYP3A4HSD17B10CCNC
SCHEMBL30783774 0.82 PIK3CB (0.39) AKT1AKT2AKT3PIK3CB
SCHEMBL30783932 0.82 PIK3CB (0.38) AKT1AKT2AKT3PIK3CB
SCHEMBL30784489 0.82 PIK3CB (0.39) AKT1AKT2AKT3PIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026424-A1 QUINAZOLINONE DERIVATIVES AS AND RELATED USES BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback